HALO AP

Voicebrook's integration with Indica’s HALO AP platform brings speech-driven command and control to digital slide review and pulls HALO Clinical AI biomarker results directly into CAP cancer checklists, eliminating manual re-entry between image analysis and the pathology report.

Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation

HALO AP, HALO Clinical AI, News, Press Releases / , , , ,

Roslyn Heights, NY and Albuquerque, NM, September 22, 2026 – Voicebrook, the leader in pathology workflow automation, driving reporting end to end, today announced a new integration partnership with Indica Labs, the trusted global leader in AI-powered digital pathology . The integration connects Voicebrook’s VoiceOver PRO reporting workflow to the Indica Labs HALO AP platform, giving pathologists hands-free control of digital slide review while allowing HALO Clinical AI-generated biomarker results to flow automatically into the appropriate CAP cancer protocol checklist.

Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation Read More »

The image shows both company logos of Indica Labs and Source LDPath showcasing the partnership. Since deploying HALO AP® at its Nottingham headquarters, Source BioScience has processed approximately 78,000 cases and 278,000 slides in under nine months with a national rollout now underway that will significantly expand digital pathology capacity across the UK’s outsourced histopathology market.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom

HALO AP, News, Press Releases / , , , ,

Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has demonstrated how an interoperable, scanner-agnostic enterprise platform can eliminate one of the greatest barriers to large-scale digital pathology outsourcing while enabling rapid laboratory growth.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom Read More »

The latest HALO AP® update is a transformative new version that introduces intelligent workflow orchestration, traceability, and multi-site collaboration to support modern diagnostic environments.

HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability

HALO AP, News, Press Releases / , ,

Albuquerque, NM, July 14, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced a new software release designed to streamline and scale digital pathology workflows through enhanced automation, collaboration, and system transparency.

HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability Read More »

Prostate Macrodissect AI enables pathologists to identify and quantify tumor-rich regions in prostate specimens with precision. Improving macrodissection accuracy, maximizing NGS tumor content, and reducing QNS failures, a critical advancement in the molecular profiling of the most commonly diagnosed cancer in men.

Indica Labs Expands into Prostate Cancer, Improving NGS ConfidenceThrough Precise Tumor Quantification

HALO AP, News, Press Releases / , ,

Albuquerque, NM, June 30, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the launch of Prostate Macrodissect AI, a clinically validated algorithm designed to automate and quantify tumor content in FFPE prostate tissue specimens. Prostate Macrodissect AI is designed to operate in concert with Indica Labs’ broader HALO Clinical AI suite, enabling laboratories to build end-to-end AI-powered prostate cancer workflows from automated tumor detection and Gleason grading assistance through to optimized macrodissection and genomic test preparation within a single, validated digital pathology platform.

Indica Labs Expands into Prostate Cancer, Improving NGS ConfidenceThrough Precise Tumor Quantification Read More »

HALO AP 2.5 introduces lab logic, a configuration layer that enables labs to tailor HALO AP® to their preferred workflow, enabling any lab, regardless of case volume, to operate like an automated triage engine, continuously analyzing incoming slides; triggering AI-driven actions; and delivering the right cases to the right experts at the right time.

Lab Logic Brings Intelligent Case Orchestration to HALO AP® and HALO AP Dx

Blogs, Clinical, Clinical Products, HALO AP, HALO AP Dx, News / , , ,

HALO AP 2.5 introduces Lab Logic. A configuration layer that enables labs to tailor HALO AP® to their preferred workflow, enabling any lab, regardless of case volume, to operate like an automated triage engine, continuously analyzing incoming slides; triggering AI-driven actions; and delivering the right cases to the right experts at the right time.

Lab Logic Brings Intelligent Case Orchestration to HALO AP® and HALO AP Dx Read More »

AI powered companion diagnostics reshaping the future of precision medicine.

Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026

HALO AP, News, Press Releases / , ,

Albuquerque, NM, May 27, 2026 – Indica Labs, the global leader in AI-powered digital pathology solutions, today announced a major expansion of its companion diagnostics (CDx) capabilities, positioning the company at the forefront of precision medicine innovation ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026 Read More »

Free Demo
Free Demo
Scroll to Top